Projects
(Principal Investigator)



Results 1-22 of 22 (Search time: 0.004 seconds).

Start DateTitleP-InvestigatorFunding Organization/經費來源
2019解碼致命性攝護腺癌的生物表現(2/3)YEONG-SHIAU PUMinistry of Science and Technology
2016Molecular Effects of a Multi-Carotenoids (MCS) New Agent on Prostate Cancer ChemopreventionYEONG-SHIAU PUMinistry of Science and Technology
2015Molecular Effects of a Multi-Carotenoids (MCS) New Agent on Prostate Cancer ChemopreventionYEONG-SHIAU PUMinistry of Science and Technology
2014Immune Profiles and Circulating Tumor Cell Status Following Prostate CryotherapyYEONG-SHIAU PUMinistry of Science and Technology
2013Immune Profiles and Circulating Tumor Cell Status Following Prostate CryotherapyYEONG-SHIAU PUMinistry of Science and Technology
2012Immune Profiles and Circulating Tumor Cell Status Following Prostate CryotherapyYEONG-SHIAU PUMinistry of Science and Technology
2011探索泌尿上皮癌細胞對gemcitabine 之化學抗藥性機制YEONG-SHIAU PUMinistry of Science and Technology
2010探索泌尿上皮癌細胞對Gemcitabine之化學抗藥性機制YEONG-SHIAU PUMinistry of Science and Technology
2009探索泌尿上皮癌細胞對Gemcitabine之化學抗藥性機制YEONG-SHIAU PUMinistry of Science and Technology
2008Prediction of Radiosensitivity of Bladder Cancer by Dna Adduct Excision ActivityYEONG-SHIAU PUMinistry of Science and Technology
2007Prediction of Radiosensitivity of Bladder Cancer by DNA Adduct Excision ActivityYEONG-SHIAU PUMinistry of Science and Technology
2006Prediction of Radiosensitivity of Bladder Cancer by DNA Adduct Excision ActivityYEONG-SHIAU PUMinistry of Science and Technology
2004Gene Expression Profiling of Human Transitional Cell Carcinoma---Identifying Arsenic-Related Carcinogenic Mechanism and Tailoring Chemotherapy Regimens (III)YEONG-SHIAU PUMinistry of Science and Technology
2003Gene Expression Profiling of Human Transitional Cell Carcinoma---Identifying Arsenic-Related Carcinogenic Mechanism and Tailoring Chemotherapy Regimens (II)YEONG-SHIAU PUMinistry of Science and Technology
2002Gene Expression Profiling of Human Transitional Cell Carcinoma---Identifying Arsenic-Related Carcinogenic Mechanism and Tailoring Chemotherapy RegimensYEONG-SHIAU PUMinistry of Science and Technology
2001Exposure of Urothelial Cells to Inorganic Arsenic and Drug Resistance Mechanisms in Arsenic-Related Transitional Cell Carcinoma (III)YEONG-SHIAU PUMinistry of Science and Technology
2001Searching Novel Treatment for Hormone-Refractory Prostate Cancer (III)YEONG-SHIAU PUMinistry of Science and Technology
2000Exposure of Urothelial Cells to Inorganic Arsenic and Drug Resistance Mechanisms in Arsenic-Related Transitional Cell Carcinoma (II)YEONG-SHIAU PUMinistry of Science and Technology
2000Searching Novel Treatment for Hormone-Refractory Prostate Cancer (II)YEONG-SHIAU PUMinistry of Science and Technology
1999Exposure of Urothelial Cells to Inorganic Arsenic and Drug Resistance Mechanisms in Arsenic-Related Transitional Cell Carcinoma (I)YEONG-SHIAU PUMinistry of Science and Technology
1999Searching Novel Treatment for Hormone-Refractory Prostate Cancer(I)YEONG-SHIAU PUMinistry of Science and Technology
1996Circumvention of Chemoresistance of Human Urothelial Carcinoma (II)---Apoptosis-Related Molecular Changes Induced by ChemotherapyYEONG-SHIAU PUMinistry of Science and Technology